Bionext Launches Biosight: an Online Platform That Will Revolutionize Pharmaceutical Research
Bionext, a bioinformatics company, announces today the launch of BioSight, an online bio-simulation platform designed for efficient identification of possible side effects of potential drug treatments on the human body. As result of fifteen years of molecular biology R&D, BioSight uses a patented algorithm that is able to predict all of the potential biological targets that are at risk of interacting with a potential drug treatment. Available as Software as a Service (SaaS) or on-site, BioSight, at an affordable price and within a few hours, enables pharmaceutical and biomedical research professionals to better develop their molecules, reduce the failure rate during the clinical trial phase and, therefore, optimize their return on investment.
3.975 billion dollars per drug
That is the average total cost of R&D needed for pharmaceutical companies to launch a new drug on the world market.1 According to LEEM, out of 10,000 target molecules, 10 will become part of patents filed and only one of those will become part of a new drug being sold. The failure rate of drug candidates is particularly high and drug research is primarily abandoned late in the R&D process and advanced stages of clinical research when side effects are most likely to become apparent. These failures typically cost upwards of hundreds of millions of dollars.
It is also estimated that around 85% of these failures occur due to biological reasons linked to problems of effectiveness or toxicity caused by interactions between the drug and targets different than the one the drug is being developed for.
Digital technologies for accelerating therapeutic innovations
With its BioSight platform, Bionext’s ambition is to completely change the current process of developing and making medications- all thanks to digital technology. Goal: lower the entry cost to the therapeutic innovation market by offering thousands of small companies, laboratories and researchers with access to technologies that were previously out of their reach.
In order to accelerate the development of BioSight and to strengthen its position in the bioinformatics market, Bionext hopes to raise more than 5 million Euros in funding over the next 18 months.
1 How Much Does Pharmaceutical Innovation Cost? Forbes, 2013
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170621005740/en/
Contact information
Yucatan for Bionext
Caroline Prince
+33-1-53-63-27-35
bionext@yucatan.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIKE, Inc. Announces Senior Leadership Changes to Accelerate Growth and Drive Win Now Action Plan5.5.2025 23:15:00 EEST | Press release
NIKE, Inc. (NYSE:NKE) announced a series of strategic changes to its Senior Leadership Team (SLT), elevating experienced leaders to accelerate progress against its Win Now action plan to position the company for future growth. Elliott Hill, President and CEO, NIKE, Inc. and Heidi O’Neill, President of Consumer, Product, and Brand, have decided the Consumer, Product, and Brand leadership will now be divided into three distinct areas: Consumer and Sport, Marketing, and Product Creation, inclusive of Innovation and Design. These roles will now report directly to Hill. As a result of these changes O’Neill has decided to retire from Nike after 26 years. She will continue to serve in an advisory capacity until September 2025. “For nearly three decades, Heidi has been a true champion for Nike, for sport and for athletes across the globe. Her vision and dedication over the years have left an indelible mark on Nike and created an impact on the world of sport,” said Hill. “Among Heidi’s many suc
LR Health & Beauty Once Again Demonstrates Its Expertise in Aloe Vera5.5.2025 17:24:00 EEST | Press release
LR Health & Beauty has been synonymous with the best Aloe Vera quality on the market for over 20 years, and continuously invests in new product innovations to take full advantage of the plant's range of beneficial properties. The majority of the over 60 products are developed and produced directly at the company headquarters in Ahlen. LR has now made a decisive breakthrough in skin care cosmetics with its unique combination of pure Aloe Vera leaf gel and fermented Aloe Vera. The care products with the highest Aloe Vera content therefore not only work in the upper and middle layers of the skin, but also unleash the full potential of Aloe Vera in the deeper layers. The effectiveness of this LR Aloe Via Magic Power Duo has been confirmed by the dermatological institute, Dermatest. All the products tested based on a combination of Aloe Vera Gel and fermented Aloe were awarded the 5-star "very good" seal by Dermatest. The test results* show increased moisture retention (up to 176%), improve
MultiBank Group Signs Strategic Partnership With MAG to Tokenize $3 Billion Real Estate Assets5.5.2025 17:09:00 EEST | Press release
MultiBank Group, the world’s largest financial derivatives institution based in Dubai has signed a historic $3 billion tokenization agreement with MAG, the leading real estate developer in the UAE, and Mavryk, a leading blockchain innovator — marking the largest real-world asset (RWA) tokenization initiative globally to date. The initiative highlights the imminent launch of $MBG, the utility token at the core of MultiBank’s next-generation digital finance ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505317631/en/ MultiBank Group Signs Strategic Partnership With MAG to Tokenize $3 Billion Real Estate Assets The partnership will bring MAG’s high-value real estate developments — The Ritz-Carlton Residences, Dubai, Creekside, which is part of the Keturah Resort, and Keturah Reserve — onto the blockchain, making them available to global investors via MultiBank.io’s fully regulated RWA marketplace. Once launched, h
3Degrees Grows Carbon Asset Development Capabilities in Singapore5.5.2025 16:30:00 EEST | Press release
3Degrees, a leading global climate solutions provider, announced today that it will be expanding its carbon asset development capabilities in Singapore. The move will see the company developing a pipeline of projects that are aligned with Article 6 of the Paris Agreement across Southeast Asia and beyond, supporting the region’s growing demand for credible, science-based climate action. The company brings nearly two decades of market experience and technical expertise to the region and is well-positioned to help operationalize Article 6 through high-integrity, scalable project development—enabling both environmental impact and market confidence. This expansion will be supported by the Singapore Economic Development Board (EDB)’s Carbon Project Development grant. The grant aims to support early-stage carbon project development and financing activities for Article 6 carbon credit projects. The initiative reinforces Singapore’s position as a global hub for high-integrity climate solutions
Sitetracker Launches Enhanced O&M Tools to Drive Efficiency Across the Asset Lifecycle5.5.2025 16:00:00 EEST | Press release
Sitetracker, the global leader in complete Asset Lifecycle Management, today announced significant enhancements to its Operations and Maintenance (O&M) solution. These advancements reinforce Sitetracker's position as the leading end-to-end platform built to help asset owners and contractors plan, build, operate, and maintain critical infrastructure at scale. As infrastructure networks grow more distributed and complex—driven by the accelerating energy transition, AI’s demand on energy and digital infrastructure, and global connectivity—operations and maintenance teams are under increasing pressure. Assets are often deployed in remote locations, teams are expected to do more with fewer resources, and the margin for error has never been slimmer. Success now depends on having intelligent, scalable tools that enable safe, efficient, and proactive asset management at every stage. “Operations and maintenance are no longer back-office functions—they're front and center in ensuring ROI and rel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom